Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 23% ± 5% | |
| epithelial cell | 5 studies | 31% ± 13% | |
| ciliated cell | 4 studies | 27% ± 9% | |
| natural killer cell | 3 studies | 20% ± 3% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| non-classical monocyte | 3 studies | 22% ± 7% | |
| B cell | 3 studies | 19% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 0% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 21% ± 5% | |
| retina horizontal cell | 3 studies | 20% ± 1% | |
| lymphocyte | 3 studies | 22% ± 5% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 20% ± 7% | |
| mature NK T cell | 3 studies | 17% ± 1% | |
| basal cell | 3 studies | 31% ± 5% | |
| goblet cell | 3 studies | 26% ± 10% | |
| neuron | 3 studies | 23% ± 6% | |
| oligodendrocyte | 3 studies | 21% ± 6% | |
| astrocyte | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 2791.24 | 21 / 21 | 100% | 17.61 | 504 / 504 |
| esophagus | 100% | 2333.27 | 1445 / 1445 | 100% | 15.89 | 183 / 183 |
| intestine | 100% | 2614.63 | 966 / 966 | 100% | 14.01 | 527 / 527 |
| lung | 100% | 2589.39 | 578 / 578 | 100% | 20.08 | 1155 / 1155 |
| prostate | 100% | 2622.32 | 245 / 245 | 100% | 11.46 | 502 / 502 |
| uterus | 100% | 2909.78 | 170 / 170 | 100% | 19.11 | 459 / 459 |
| brain | 100% | 2190.27 | 2639 / 2642 | 100% | 17.18 | 705 / 705 |
| breast | 100% | 2742.84 | 459 / 459 | 100% | 14.28 | 1115 / 1118 |
| thymus | 100% | 2484.43 | 653 / 653 | 100% | 14.35 | 603 / 605 |
| stomach | 100% | 2010.48 | 359 / 359 | 100% | 12.17 | 285 / 286 |
| ovary | 100% | 2830.51 | 180 / 180 | 100% | 13.07 | 428 / 430 |
| skin | 100% | 2997.69 | 1809 / 1809 | 99% | 18.55 | 469 / 472 |
| kidney | 100% | 1974.45 | 89 / 89 | 99% | 10.62 | 892 / 901 |
| pancreas | 100% | 1404.77 | 328 / 328 | 99% | 13.35 | 176 / 178 |
| adrenal gland | 100% | 2111.74 | 258 / 258 | 97% | 11.88 | 224 / 230 |
| liver | 100% | 1204.45 | 226 / 226 | 93% | 7.70 | 377 / 406 |
| adipose | 100% | 2521.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2142.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.81 | 29 / 29 |
| muscle | 100% | 1831.14 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3255.37 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 14.10 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.35 | 1 / 1 |
| heart | 100% | 1604.32 | 857 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 11.37 | 78 / 80 |
| peripheral blood | 95% | 1545.31 | 884 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0045596 | Biological process | negative regulation of cell differentiation |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
| GO_0008150 | Biological process | biological_process |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0140288 | Cellular component | GBAF complex |
| GO_0016514 | Cellular component | SWI/SNF complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0070577 | Molecular function | lysine-acetylated histone binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003676 | Molecular function | nucleic acid binding |
| Gene name | BRD9 |
| Protein name | Bromodomain containing 9 Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8) |
| Synonyms | UNQ3040/PRO9856 |
| Description | FUNCTION: Plays a role in chromatin remodeling and regulation of transcription . Acts as a chromatin reader that recognizes and binds acylated histones: binds histones that are acetylated and/or butyrylated . Component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner . Orchestrates also the RAD51-RAD54 complex formation and thereby plays a role in homologous recombination (HR) . . |
| Accessions | H0YAW8 H0YBR9 H0YBF1 ENST00000519112.5 ENST00000523139.5 C9JBY0 ENST00000466684.5 ENST00000518251.1 ENST00000489093.1 F2Z2E8 ENST00000518250.5 ENST00000483173.5 [Q9H8M2-6] ENST00000467963.6 [Q9H8M2-5] ENST00000490814.6 Q9H8M2 ENST00000489816.5 H0YBX9 ENST00000495265.5 ENST00000487688.1 |